Skip to content
healthcare.dev

Burn Treatment

NDC 49687-0014, BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE, cream, from CMC Group Inc..

Product NDC
49687-0014
Status
Listed
Labeler
CMC Group Inc.
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M003
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49687-0014 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENZALKONIUM CHLORIDE.13 g/100g
  • LIDOCAINE HYDROCHLORIDE.5 g/100g

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
49687-0014-04968700140010 POUCH in 1 KIT (49687-0014-0) / .9 g in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49687-0014 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49687-0014 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49687-0014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.